These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 16700419)
61. Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws. Dodson TB J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):44-52. PubMed ID: 19371814 [TBL] [Abstract][Full Text] [Related]
62. A time for perspective on bisphosphonates. Assael LA J Oral Maxillofac Surg; 2006 Jun; 64(6):877-9. PubMed ID: 16713799 [No Abstract] [Full Text] [Related]
63. Bisphosphonates and avascular necrosis of the jaws. Carter GD; Goss AN Aust Dent J; 2003 Dec; 48(4):268. PubMed ID: 14738134 [No Abstract] [Full Text] [Related]
64. [Osteonecrosis of the jaws during treatment with bisphosphonates: diagnosis and therapy]. Steiner B; Lenz JH; Gundlach KK; Freund M Dtsch Med Wochenschr; 2005 Sep; 130(38):2142-5. PubMed ID: 16172955 [No Abstract] [Full Text] [Related]
65. Bisphosphonate-associated osteonecrosis of the jaws. Schwartz HC J Oral Maxillofac Surg; 2005 Oct; 63(10):1555-6. PubMed ID: 16182929 [No Abstract] [Full Text] [Related]
67. [Osteonecrosis of the jaws by long term therapy with bisphosphonates]. Piesold JU; Al-Nawas B; Grötz KA Mund Kiefer Gesichtschir; 2006 Sep; 10(5):287-300. PubMed ID: 16960697 [TBL] [Abstract][Full Text] [Related]
68. Osteonecrosis of the jaw associated with zoledronate therapy in a patient with multiple myeloma. Vannucchi AM; Ficarra G; Antonioli E; Bosi A Br J Haematol; 2005 Mar; 128(6):738. PubMed ID: 15755276 [No Abstract] [Full Text] [Related]
69. Necrotizing fasciitis secondary to bisphosphonate-induced osteonecrosis of the jaw. Setabutr D; Hales NW; Krempl GA Am J Otolaryngol; 2010; 31(2):127-9. PubMed ID: 20015718 [TBL] [Abstract][Full Text] [Related]
70. Recent reports link bisphosphonates use to osteonecrosis. Marunick M; Miller R; Gordon S Todays FDA; 2006 Mar; 18(3):26-31. PubMed ID: 16639805 [No Abstract] [Full Text] [Related]
71. Role of ozone therapy in the treatment of osteonecrosis of the jaws in multiple myeloma patients. Petrucci MT; Gallucci C; Agrillo A; Mustazza MC; Foà R Haematologica; 2007 Sep; 92(9):1289-90. PubMed ID: 17768133 [TBL] [Abstract][Full Text] [Related]
73. Osteonecrosis of the jaw and bisphosphonates. Maerevoet M; Martin C; Duck L N Engl J Med; 2005 Jul; 353(1):99-102; discussion 99-102. PubMed ID: 16003838 [No Abstract] [Full Text] [Related]
74. Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1. Alonci A; Allegra A; Bellomo G; Quartarone E; Oteri G; Nastro E; Cicciù D; De Ponte FS; Musolino C Leuk Lymphoma; 2007 Sep; 48(9):1852-4. PubMed ID: 17786724 [No Abstract] [Full Text] [Related]
75. Use of bisphosphonates in multiple myeloma: IMWG response to Mayo Clinic consensus statement. Durie BG Mayo Clin Proc; 2007 Apr; 82(4):516-7; author reply 517-8. PubMed ID: 17418085 [No Abstract] [Full Text] [Related]
76. Osteonecrosis of the jaw and bisphosphonates. Khan A BMJ; 2010 Feb; 340():c246. PubMed ID: 20124367 [No Abstract] [Full Text] [Related]
77. The buzz about bisphosphonates. Farrar SK LDA J; 2005; 64(3):27. PubMed ID: 16639795 [No Abstract] [Full Text] [Related]
78. [Bisphosphonate-related osteonecrosis of the jaws. An update]. Cardona F; Bagán JV; Sáinz E; Figuerido J; Giner F; Vidán FJ An Sist Sanit Navar; 2009; 32(3):413-21. PubMed ID: 20094102 [TBL] [Abstract][Full Text] [Related]
79. The dilemma of jaw osteonecrosis in patients with multiple myeloma. Gertz MA; Koka S Leuk Lymphoma; 2008 Nov; 49(11):2037-9. PubMed ID: 19021045 [No Abstract] [Full Text] [Related]
80. Osteonecrosis of the jaw: what do bisphosphonates do? Aspenberg P Expert Opin Drug Saf; 2006 Nov; 5(6):743-5. PubMed ID: 17044800 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]